Satsuma Pharmaceuticals Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Satsuma Pharmaceuticals's estimated annual revenue is currently $6M per year.(i)
Satsuma Pharmaceuticals's estimated revenue per employee is $201,000

Name	Title	Email/Phone
1 Tom O'Neil	CFO	Reveal Email/Phone
2 Shannon Strom	VP and Head Regulatory Affairs	Reveal Email/Phone
3 Mic Iwashima	VP and Head Operations	Reveal Email/Phone
4 Rob Schultz	SVP amd Head CMC	Reveal Email/Phone
5 Cindy Zhong	Senior Director Operations	Reveal Email/Phone
6 Rob Janosky	Chief Commercial Officer	Reveal Email/Phone
7 Tammy Tyner	Quality Assurance Manager	Reveal Email/Phone
8 John Jennings	Analytical Manager	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Meissner Filtra...	$84.8M	422	24%	N/A	N/A
#2 Otitopic	$0.4M	2	0%	N/A	N/A
#3 Trifecta Clinic...	$32M	159	3%	N/A	N/A
#4 DURECT Corporat...	$35M	121	3%	$62.5M	N/A
#5 Rancho BioScien...	$30.2M	150	18%	N/A	N/A
#6 Amylin Pharmace...	$135.3M	673	0%	N/A	N/A
#7 ApotheCom	$110.3M	549	N/A	N/A	N/A
#8 Mylan Specialty	$60.1M	299	-4%	N/A	N/A
#9 SK pharmteco	$554.8M	1725	2%	N/A	N/A
#10 Tlc Pharmacy	$10.5M	52	4%	N/A	N/A

Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers.

keywords:N/A

N/A

Total Funding

Number of Employees

$6M

Revenue (est)

-32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Satsuma Pharmaceuticals Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2022 Annual Meeting ; Session: P13:...

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product, STS101, for the acute treatment of...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Saga Musical In...	$7.5M	31	-9%	N/A
#2 Applied Molecul...	$23.4M	31	-65%	N/A
#3 TerraVia	$15M	31	0%	$3.5M
#4 Zenflow	$7.8M	31	-6%	N/A
#5 Blade Therapeut...	$5M	32	-14%	N/A